Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia

Esther S. Oh, Kaj Blennow, George E. Bigelow, Sharon K. Inouye, Edward R. Marcantonio, Karin J. Neufeld, Paul B. Rosenberg, Juan C. Troncoso, Nae Yuh Wang, Henrik Zetterberg, Frederick E. Sieber, Constantine G. Lyketsos

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Background There is strong association of Alzheimer's disease (AD) pathology with gait disorder and falls in older adults without dementia. The goal of the study was to examine the prevalence and severity of AD pathology in older adults without dementia who fall and sustain hip fracture. Methods Cerebrospinal fluid (CSF) was obtained from 168 hip fracture patients. CSF Aβ42/40 ratio, p-tau, and t-tau measures were dichotomized into normal vs. abnormal, and categorized according to the A/T/N classification. Results Among the hip fracture patients, 88.6% of the cognitively normal (Clinical Dementia Rating- CDR 0; n = 70) and 98.8% with mild cognitive impairment (CDR 0.5; n = 81) fell in the abnormal biomarker categories by the A/T/N classification. Conclusions A large proportion of older hip fracture patients have CSF evidence of AD pathology. Preoperative determination of AD biomarkers may play a crucial role in identifying persons without dementia who have underlying AD pathology in perioperative settings.

Original languageEnglish (US)
Article numbere0204695
JournalPloS one
Issue number9
StatePublished - Sep 2018

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia'. Together they form a unique fingerprint.

Cite this